AI accelerates the search for new tuberculosis drug targets
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air...
Research
The Ozempic boom is slowing down
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish pharmaceutical giant warns...
Omega-3s can slow down aging process
Many people would like to delay or even stop the aging process. Previous clinical studies have shown that a reduced...
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
ERLANGEN, GERMANY AND VILNIUS, LITHUANIA, Feb 4, 2025 - (ACN Newswire) - Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing novel treatments...
Cardiovascular disease medications underused globally
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to...
Gene therapy may be “one shot stop” for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must...
Big Pharma has a big Super Bowl dilemma
Big Pharma often turns to NFL games to hawk their blockbuster treatments, but drug makers have typically been hesitant to...
Astrazeneca cancels million-pound investment in UK vaccine factory
The pharmaceutical giant AstraZeneca has cancelled plans to invest £450 million in a vaccine manufacturing plant in Merseyside - blaming...
Astrazeneca cancels £450m vaccine plant, blaming state funding cut
Astrazeneca has cancelled a planned £450m investment in a vaccine manufacturing plant in Merseyside, saying Labour have failed to match...
Researchers identify genetic 'fingerprint' to predict drug resistance in bacteria
Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World...
KAI Conversations Secures New Investment Round, Set to Unveil Revolutionary AI Coach for Pharma Representatives
Thursday 30 January, 2025 London, January 30, 2025 - KAI Conversations, the world's leading AI-driven conversation intelligence platform for pharmaceutical...
